Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Rheumatoid Arthritis

  Free Subscription


Articles published in Curr Opin Rheumatol

Retrieve available abstracts of 54 articles:
HTML format



Single Articles


    May 2021
  1. REDDY V, Cohen S
    Role of Janus Kinase inhibitors in rheumatoid arthritis treatment.
    Curr Opin Rheumatol. 2021;33:300-306.
    PubMed     Abstract available


  2. SINGH N, Li CI
    Impact of rheumatoid arthritis and biologic and targeted synthetic disease modifying antirheumatic agents on cancer risk and recurrence.
    Curr Opin Rheumatol. 2021;33:292-299.
    PubMed     Abstract available


    March 2021
  3. REDDY V, Cohen S
    Role of Janus Kinase inhibitors in rheumatoid arthritis treatment.
    Curr Opin Rheumatol. 2021 Mar 23. pii: 00002281-900000000-98906.
    PubMed     Abstract available


    February 2021
  4. WYSHAM KD, Baker JF, Shoback DM
    Osteoporosis and fractures in rheumatoid arthritis.
    Curr Opin Rheumatol. 2021 Feb 26. pii: 00002281-900000000-98914.
    PubMed     Abstract available


  5. MOORE MN, Wallace BI
    Glucocorticoid and opioid use in rheumatoid arthritis management.
    Curr Opin Rheumatol. 2021 Feb 22. pii: 00002281-900000000-98917.
    PubMed     Abstract available


  6. MCDERMOTT GC, Doyle TJ, Sparks JA
    Interstitial lung disease throughout the rheumatoid arthritis disease course.
    Curr Opin Rheumatol. 2021 Feb 22. pii: 00002281-900000000-98916.
    PubMed     Abstract available


  7. D'SILVA KM, Wallace ZS
    COVID-19 and rheumatoid arthritis.
    Curr Opin Rheumatol. 2021 Feb 22. pii: 00002281-900000000-98915.
    PubMed     Abstract available


    January 2021
  8. LAKHANPAL A, Smith MH, Donlin LT
    Rheumatology in the era of precision medicine: synovial tissue molecular patterns and treatment response in rheumatoid arthritis.
    Curr Opin Rheumatol. 2021;33:58-63.
    PubMed     Abstract available


    December 2020
  9. YIP K, Navarro-Millan I
    Racial, ethnic, and healthcare disparities in rheumatoid arthritis.
    Curr Opin Rheumatol. 2020;Publish Ahead of Print.
    PubMed     Abstract available


    September 2020
  10. PECLAT TR, Shi B, Varga J, Chini EN, et al
    The NADase enzyme CD38: an emerging pharmacological target for systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritis.
    Curr Opin Rheumatol. 2020 Sep 15. doi: 10.1097/BOR.0000000000000737.
    PubMed     Abstract available


    May 2020
  11. JEURLING S, Cappelli LC
    Treatment of immune checkpoint inhibitor-induced inflammatory arthritis.
    Curr Opin Rheumatol. 2020;32:315-320.
    PubMed     Abstract available


    March 2020
  12. GREENBLATT HK, Kim HA, Bettner LF, Deane KD, et al
    Preclinical rheumatoid arthritis and rheumatoid arthritis prevention.
    Curr Opin Rheumatol. 2020 Mar 19. doi: 10.1097/BOR.0000000000000708.
    PubMed     Abstract available


  13. CARSTENSEN SMD, Terslev L, Jensen MP, Ostergaard M, et al
    Future use of musculoskeletal ultrasonography and magnetic resonance imaging in rheumatoid arthritis.
    Curr Opin Rheumatol. 2020 Mar 19. doi: 10.1097/BOR.0000000000000709.
    PubMed     Abstract available


  14. BARTON JL, Decary S
    New galaxies in the universe of shared decision-making and rheumatoid arthritis.
    Curr Opin Rheumatol. 2020 Mar 5. doi: 10.1097/BOR.0000000000000699.
    PubMed     Abstract available


  15. ENGLAND BR, Hershberger D
    Management issues in rheumatoid arthritis-associated interstitial lung disease.
    Curr Opin Rheumatol. 2020 Mar 5. doi: 10.1097/BOR.0000000000000703.
    PubMed     Abstract available


  16. PRISCO LC, Martin LW, Sparks JA
    Inhalants other than personal cigarette smoking and risk for developing rheumatoid arthritis.
    Curr Opin Rheumatol. 2020 Mar 5. doi: 10.1097/BOR.0000000000000705.
    PubMed     Abstract available


  17. KATZ P, Andonian BJ, Huffman KM
    Benefits and promotion of physical activity in rheumatoid arthritis.
    Curr Opin Rheumatol. 2020 Mar 5. doi: 10.1097/BOR.0000000000000696.
    PubMed     Abstract available


  18. ANDONIAN BJ, Huffman KM
    Skeletal muscle disease in rheumatoid arthritis: the center of cardiometabolic comorbidities?
    Curr Opin Rheumatol. 2020 Mar 5. doi: 10.1097/BOR.0000000000000697.
    PubMed     Abstract available


    January 2020
  19. ARGYROPOULOU OD, Tzioufas AG
    Common and rare forms of vasculitis associated with Sjogren's syndrome.
    Curr Opin Rheumatol. 2020;32:21-28.
    PubMed     Abstract available


  20. GOEL RR, Kaplan MJ
    Deadliest catch: neutrophil extracellular traps in autoimmunity.
    Curr Opin Rheumatol. 2020;32:64-70.
    PubMed     Abstract available


    December 2019
  21. WEYAND CM, Wu B, Goronzy JJ
    The metabolic signature of T cells in rheumatoid arthritis.
    Curr Opin Rheumatol. 2019 Dec 31. doi: 10.1097/BOR.0000000000000683.
    PubMed     Abstract available


    November 2019

  22. Porphyromonas gingivalis and rheumatoid arthritis: Erratum.
    Curr Opin Rheumatol. 2019;31:697.
    PubMed    


    October 2019
  23. COUTANT F, Miossec P
    Evolving concepts of the pathogenesis of rheumatoid arthritis with focus on the early and late stages.
    Curr Opin Rheumatol. 2019 Oct 21. doi: 10.1097/BOR.0000000000000664.
    PubMed     Abstract available


    September 2019
  24. LUCCHESE A
    Periodontal bacteria and the rheumatoid arthritis-related antigen RA-A47: the cross-reactivity potential.
    Curr Opin Rheumatol. 2019;31:542-545.
    PubMed     Abstract available


    July 2019
  25. PERRICONE C, Ceccarelli F, Matteo S, Di Carlo G, et al
    Porphyromonas gingivalis and rheumatoid arthritis.
    Curr Opin Rheumatol. 2019 Jul 1. doi: 10.1097/BOR.0000000000000638.
    PubMed     Abstract available


    May 2019
  26. LOWIN T, Schneider M, Pongratz G
    Joints for joints: cannabinoids in the treatment of rheumatoid arthritis.
    Curr Opin Rheumatol. 2019;31:271-278.
    PubMed     Abstract available


  27. GEORGE MD, Baker JF
    Perioperative management of immunosuppression in patients with rheumatoid arthritis.
    Curr Opin Rheumatol. 2019;31:300-306.
    PubMed     Abstract available


    March 2019
  28. DAY AL, Curtis JR
    Opioid use in rheumatoid arthritis: trends, efficacy, safety, and best practices.
    Curr Opin Rheumatol. 2019 Mar 5. doi: 10.1097/BOR.0000000000000602.
    PubMed     Abstract available


    February 2019
  29. JANI M, Barton A, Hyrich K
    Prediction of infection risk in rheumatoid arthritis patients treated with biologics: are we any closer to risk stratification?
    Curr Opin Rheumatol. 2019 Feb 14. doi: 10.1097/BOR.0000000000000598.
    PubMed     Abstract available


  30. VALLERAND IA, Patten SB, Barnabe C
    Depression and the risk of rheumatoid arthritis.
    Curr Opin Rheumatol. 2019 Feb 14. doi: 10.1097/BOR.0000000000000597.
    PubMed     Abstract available


  31. HSIAO B, Fraenkel L
    Patient preferences for rheumatoid arthritis treatment.
    Curr Opin Rheumatol. 2019 Feb 11. doi: 10.1097/BOR.0000000000000591.
    PubMed     Abstract available


    April 2018
  32. VAN DE SANDE MGH, van Vollenhoven RF
    Evolution of clinical trials for rheumatoid arthritis and spondyloarthritis.
    Curr Opin Rheumatol. 2018 Apr 24. doi: 10.1097/BOR.0000000000000516.
    PubMed     Abstract available


    March 2018
  33. SAKKAS LI, Bogdanos DP
    Multiple hit infection and autoimmunity: the dysbiotic microbiota-ACPA connection in rheumatoid arthritis.
    Curr Opin Rheumatol. 2018 Mar 13. doi: 10.1097/BOR.0000000000000503.
    PubMed     Abstract available


  34. PONTARINI E, Lucchesi D, Bombardieri M
    Current views on the pathogenesis of Sjogren's syndrome.
    Curr Opin Rheumatol. 2018;30:215-221.
    PubMed     Abstract available


  35. HAMMAKER D, Firestein GS
    Epigenetics of inflammatory arthritis.
    Curr Opin Rheumatol. 2018;30:188-196.
    PubMed     Abstract available


    February 2018
  36. GILES JT
    Getting personal: towards individualized management of rheumatoid arthritis.
    Curr Opin Rheumatol. 2018 Feb 19. doi: 10.1097/BOR.0000000000000499.
    PubMed    


  37. MAHAJAN TD, Mikuls TR
    Recent advances in the treatment of rheumatoid arthritis.
    Curr Opin Rheumatol. 2018 Feb 15. doi: 10.1097/BOR.0000000000000496.
    PubMed     Abstract available


  38. BONELLI M, Scheinecker C
    How does abatacept really work in rheumatoid arthritis?
    Curr Opin Rheumatol. 2018 Feb 3. doi: 10.1097/BOR.0000000000000491.
    PubMed     Abstract available


    January 2018
  39. REGIERER AC, Strangfeld A
    Rheumatoid arthritis treatment in patients with a history of cancer.
    Curr Opin Rheumatol. 2018 Jan 31. doi: 10.1097/BOR.0000000000000492.
    PubMed     Abstract available


  40. DEN BROEDER AA, van Herwaarden N, van den Bemt BJF
    Therapeutic drug monitoring of biologicals in rheumatoid arthritis: a disconnect between beliefs and facts.
    Curr Opin Rheumatol. 2018 Jan 31. doi: 10.1097/BOR.0000000000000487.
    PubMed     Abstract available


  41. DIXON WG, Michaud K
    Using technology to support clinical care and research in rheumatoid arthritis.
    Curr Opin Rheumatol. 2018 Jan 23. doi: 10.1097/BOR.0000000000000485.
    PubMed     Abstract available


  42. BERGSTRA SA, Allaart CF
    What is the optimal target for treat-to-target strategies in rheumatoid arthritis?
    Curr Opin Rheumatol. 2018 Jan 19. doi: 10.1097/BOR.0000000000000484.
    PubMed     Abstract available


  43. SLOWIKOWSKI K, Wei K, Brenner MB, Raychaudhuri S, et al
    Functional genomics of stromal cells in chronic inflammatory diseases.
    Curr Opin Rheumatol. 2018;30:65-71.
    PubMed     Abstract available


    December 2017
  44. RIDGLEY LA, Anderson AE, Pratt AG
    What are the dominant cytokines in early rheumatoid arthritis?
    Curr Opin Rheumatol. 2017 Dec 4. doi: 10.1097/BOR.0000000000000470.
    PubMed     Abstract available


    September 2017
  45. DARRAH E, Andrade F
    Rheumatoid arthritis and citrullination.
    Curr Opin Rheumatol. 2017 Sep 21. doi: 10.1097/BOR.0000000000000452.
    PubMed     Abstract available


    July 2017
  46. BOGDANOS DP, Sakkas LI
    From microbiome to infectome in autoimmunity.
    Curr Opin Rheumatol. 2017;29:369-373.
    PubMed     Abstract available


  47. RAYCHAUDHURI SK, Raychaudhuri SP
    Janus kinase/signal transducer and activator of transcription pathways in spondyloarthritis.
    Curr Opin Rheumatol. 2017;29:311-316.
    PubMed     Abstract available


  48. TANAY A
    Chikungunya virus and autoimmunity.
    Curr Opin Rheumatol. 2017;29:389-393.
    PubMed     Abstract available


  49. WANG Z, Chang C, Lu Q
    Epigenetics of CD4+ T cells in autoimmune diseases.
    Curr Opin Rheumatol. 2017;29:361-368.
    PubMed     Abstract available


    April 2017
  50. BRAGAZZI NL, Watad A, Neumann SG, Simon M, et al
    Vitamin D and rheumatoid arthritis: an ongoing mystery.
    Curr Opin Rheumatol. 2017 Apr 29. doi: 10.1097/BOR.0000000000000397.
    PubMed     Abstract available


  51. ATZENI F, Masala IF, di Franco M, Sarzi-Puttini P, et al
    Infections in rheumatoid arthritis.
    Curr Opin Rheumatol. 2017 Apr 18. doi: 10.1097/BOR.0000000000000389.
    PubMed     Abstract available


    March 2017
  52. HSIAO B, Fraenkel L
    Incorporating the patient's perspective in outcomes research.
    Curr Opin Rheumatol. 2017;29:144-149.
    PubMed     Abstract available


  53. VAN DER WOUDE D, Toes RE
    The contribution of autoantibodies to post-translationally modified proteins to inflammatory arthritis.
    Curr Opin Rheumatol. 2017;29:195-200.
    PubMed     Abstract available


  54. HAHN M, Frey S, Hueber AJ
    The novel interleukin-1 cytokine family members in inflammatory diseases.
    Curr Opin Rheumatol. 2017;29:208-213.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: